• Publications
  • Influence
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
BACKGROUND Percutaneous coronary intervention (PCI) involving drug-eluting stents is increasingly used to treat complex coronary artery disease, although coronary-artery bypass grafting (CABG) hasExpand
  • 3,217
  • 162
  • PDF
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
BACKGROUND The need for repeated treatment of restenosis of a treated vessel remains the main limitation of percutaneous coronary revascularization. Because sirolimus (rapamycin) inhibits theExpand
  • 3,136
  • 69
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
BACKGROUND Patients at high risk for bleeding who undergo percutaneous coronary intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet therapy. We studied aExpand
  • 467
  • 24
  • PDF
Cyclosporine before PCI in Patients with Acute Myocardial Infarction.
BACKGROUND Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improveExpand
  • 395
  • 24
  • PDF
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy
Background— The prospective, multinational, randomized Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial was designed to assess the optimalExpand
  • 554
  • 21
Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary
Background— Current guidelines recommend coronary artery bypass graft surgery (CABG) when treating significant de novo left main coronary artery (LM) stenosis; however, percutaneous coronaryExpand
  • 351
  • 20
  • PDF
Transfemoral aortic valve implantation new criteria to predict vascular complications.
OBJECTIVES This study sought to evaluate the incidence, impact, and predictors of vascular complications in transcatheter aortic valve implantation (TAVI). BACKGROUND Vascular complicationsExpand
  • 417
  • 18
  • PDF
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
AIMS Coronary artery bypass grafting (CABG) has been considered the standard of care for patients with three-vessel disease (3VD), but long-term comparative results from randomized trials of CABG vs.Expand
  • 224
  • 15
  • PDF
The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with
OBJECTIVES The study sought to evaluate the clinical impact of angiographic complete (CR) and incomplete (ICR) revascularization and its association with the presence of total occlusions (TO), afterExpand
  • 197
  • 14
  • PDF
Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis.
OBJECTIVES The purpose of this study was to clarify the impact of sex-related differences in transcatheter aortic valve implantation (TAVI) for high-risk patients with severe aortic stenosis. Expand
  • 146
  • 13
  • PDF